Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,570.88
(0.44%)
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)

Control Bionics Ltd

CBL

ASX

Control Bionics Limited (CBL) is a pioneering medical device company dedicated to supporting patients facing challenges in verbal and textual communication due to illnesses such as Motor Neurone Disease (MND) and Amyotrophic Lateral Sclerosis (ALS). Operating across North America, Australia, Singapore, and Japan, Control Bionics leverages innovative technology to provide solutions that empower individuals with limited communication abilities. Their efforts focus on enhancing accessibility and improving quality of life through advanced assistive devices tailored to meet the unique needs of patients worldwide.

Latest Posts

Line Chart with Gradient
Price
$0.060
0 (0%)
At Close 22/11 (AEST)
Related Companies
IMAGION BIOSYSTEMS LIMITED
$IBX
IMEXHS LIMITED
$IME
RESPIRI LIMITED
$RSH
SINGULAR HEALTH GROUP LTD
$SHG
NEXT SCIENCE LIMITED
$NXS

Leave a Comment on CBL


Comments for CBL

    Latest Posts

    control-bionics-asx-cbl-unveils-new-assistive-technology-advancements-cbl
    Health Care $CBL
    Control Bionics (ASX: $CBL) unveils new assistive technology advancementsCompany expands its global presence with innovative EMG-based solutions like NeuroNode and NeuroStrip
    November 8, 2024
    control-bionics-asx-cbl-reports-strong-quarterly-performance-cbl
    Health Care $CBL
    Control Bionics (ASX: $CBL) reports strong quarterly performanceAchieves nearly 40% increase in cash receipts, strategic partnerships and new product developments
    October 17, 2024
    control-bionics-asx-cbl-reports-significant-increase-in-ndis-approvals-and-launches-new-leasing-programs-cbl
    Health Care $CBL

    Control Bionics (ASX: $CBL) reports significant increase in NDIS approvals and launches new leasing programs

    NDIS approvals surge and new leasing programs launched for Trilogy and NeuroNode systems

    October 4, 2024
    control-bionics-asx-cbl-completes-share-placement-subject-to-shareholder-approval-cbl
    Health Care $CBL

    Control Bionics (ASX: $CBL) completes share placement subject to shareholder approval

    Agreements to place shares raise $1.15m before AGM approval

    September 23, 2024
    control-bionics-asx-cbl-seeks-shareholder-approval-for-additional-share-issue-cbl
    Health Care $CBL

    Control Bionics (ASX: $CBL) seeks shareholder approval for additional share issue

    Company clarifies approval sought for $1m share placement and updates rights issue timetable

    September 20, 2024
    control-bionics-asx-cbl-announces-equity-raising-through-non-renounceable-rights-issue-cbl
    Health Care $CBL

    Control Bionics (ASX: $CBL) announces equity raising through non-renounceable rights issue

    Company intends to raise $2,092,868 via issue of up to 29,898,111 shares to eligible shareholders

    September 19, 2024
    control-bionics-asx-cbl-announces-non-renounceable-rights-issue-and-private-placement-cbl
    Health Care $CBL

    Control Bionics (ASX: $CBL) announces non-renounceable rights issue and private placement

    Company raising capital to accelerate growth initiatives and expand market presence

    September 19, 2024
    control-bionics-asx-cbl-unveils-next-generation-assistive-technology-and-data-measurement-cbl
    Health Care $CBL

    Control Bionics (ASX: $CBL) unveils next-generation assistive technology and data measurement

    Proven core technology empowering communication and enhancing lives with regulatory clearance and patent protection in key markets

    September 19, 2024
    control-bionics-asx-cbl-requests-trading-halt-for-proposed-placement-and-rights-issue-cbl
    Health Care $CBL

    Control Bionics (ASX: $CBL) requests trading halt for proposed placement and rights issue

    Company requests halt pending finalization of terms for proposed placement and rights issue

    September 19, 2024
    control-bionics-asx-cbl-expands-reach-with-exclusive-uk-and-ireland-distribution-agreement-cbl
    Health Care $CBL

    Control Bionics (ASX: $CBL) expands reach with exclusive UK and Ireland distribution agreement

    Strategic partnership to distribute NeuroNode® device for individuals with neurological disorders

    September 9, 2024
    control-bionics-asx-cbl-completes-successful-1-04m-placement-cbl
    Health Care $CBL

    Control Bionics (ASX: $CBL) completes successful $1.04m placement

    Raises A$1.04m via issue of new shares at A$0.043 per share

    May 15, 2024
    control-bionics-asx-cbl-reports-increased-cash-receipts-and-progress-on-drove-project-cbl
    Health Care $CBL

    Control Bionics (ASX: $CBL) reports increased cash receipts and progress on DROVE project

    Company sees growth in sales and R&D investment for new products

    April 26, 2024
    control-bionics-asx-cbl-empowers-communication-and-enhances-lives-with-next-generation-emg-technology-cbl
    Health Care $CBL

    Control Bionics (ASX: $CBL) empowers communication and enhances lives with next-generation EMG technology

    Proven medical device company with regulatory clearance and patent protection in key markets

    April 24, 2024

    CBL

    $CBL

    Control Bionics (ASX: $CBL) completes successful $1.04m placement

    Raises A$1.04m via issue of new shares at A$0.043 per share

    CBL

    $CBL

    Control Bionics (ASX: $CBL) reports increased cash receipts and progress on DROVE project

    Company sees growth in sales and R&D investment for new products

    CBL

    $CBL

    Control Bionics (ASX: $CBL) empowers communication and enhances lives with next-generation EMG technology

    Proven medical device company with regulatory clearance and patent protection in key markets

    Load More
    No More Posts
    Related Companies
    TRIVARX LTD
    $TRI
    ARTRYA LIMITED
    $AYA
    FREEDOM CARE GROUP HOLDINGS LIMITED
    $FCG
    VISIONFLEX GROUP LIMITED
    $VFX
    PACIFIC SMILES GROUP LIMITED
    $PSQ

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions